Eureka Therapeutics, Inc. - 10%+ Owner at Estrella Immunopharma, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Stock Symbol
ESLA, ESLAW on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Eureka Therapeutics, Inc. since 8/21/2023

Holdings reported by Eureka Therapeutics, Inc. for Estrella Immunopharma, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 25.3M Sep 29, 2023 Direct

There are no transactions reported by Eureka Therapeutics, Inc. for Estrella Immunopharma, Inc.